NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.8300
+0.0700 (9.21%)
At close: Apr 2, 2026, 4:00 PM EDT
0.7972
-0.0328 (-3.95%)
After-hours: Apr 2, 2026, 4:18 PM EDT

NeuroSense Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.173.382.643.5411.06
Short-Term Investments
---3.55-
Cash & Short-Term Investments
0.173.382.647.0911.06
Cash Growth
-95.09%27.96%-62.76%-35.91%1482.69%
Other Receivables
0.570.160.170.130.18
Receivables
0.570.160.170.130.18
Inventory
-0.74---
Prepaid Expenses
-0.090.070.120.13
Other Current Assets
0.050.040.040.040.04
Total Current Assets
0.784.42.927.3811.41
Property, Plant & Equipment
0.230.150.250.310.02
Other Long-Term Assets
0.020.020.020.02-
Total Assets
1.034.583.197.7211.43
Accounts Payable
0.81.161.460.50.04
Accrued Expenses
-0.761.931.160.56
Current Portion of Leases
-0.070.070.06-
Other Current Liabilities
1.72----
Total Current Liabilities
2.521.993.461.730.6
Long-Term Leases
0.07-0.070.15-
Other Long-Term Liabilities
--1.41-1.83
Total Liabilities
2.591.994.941.872.43
Additional Paid-In Capital
46.2339.2424.3621.8617.45
Retained Earnings
-47.79-36.66-26.12-16.01-8.45
Shareholders' Equity
-1.562.58-1.765.849.01
Total Liabilities & Equity
1.034.583.197.7211.43
Total Debt
0.070.070.140.21-
Net Cash (Debt)
0.093.312.56.8811.06
Net Cash Growth
-97.16%32.31%-63.69%-37.82%1482.69%
Net Cash Per Share
0.000.180.180.601.77
Filing Date Shares Outstanding
32.5623.9915.611.7910.94
Total Common Shares Outstanding
32.5623.2315.3811.7810.94
Working Capital
-1.742.41-0.545.6610.82
Book Value Per Share
-0.050.11-0.110.500.82
Tangible Book Value
-1.562.58-1.765.849.01
Tangible Book Value Per Share
-0.050.11-0.110.500.82
Machinery
-0.120.120.090.02
Leasehold Improvements
-000-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q